Endocrinology / diabetes clinical trials recruiting in Illinois

247 recruiting endocrinology / diabetes trials match in Illinois. Showing 20.

• ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsRecruiting

  Phase 1 / Phase 2 · Immatics US, Inc. · Chicago, Illinois

• An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Recruiting

  Phase 3 · AstraZeneca · Chicago, Illinois

• Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial CarcinomaRecruiting

  Phase 2 · National Cancer Institute (NCI) · Danville, Illinois

• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRecruiting

  Phase 2 · Eli Lilly and Company · Chicago, Illinois

• NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)Recruiting

  Phase 1 / Phase 2 · St. Jude Children's Research Hospital · Chicago, Illinois

• Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsRecruiting

  Phase 1 · Whitehawk Therapeutics, Inc. · Grand Rapids, Michigan

• Achieving Routine Intervention and Screening for Emotional HealthRecruiting

  N/A · University of Chicago · Chicago, Illinois

• Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)Recruiting

  N/A · Northwestern University · Chicago, Illinois

• Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom MonitoringRecruiting

  N/A · Carevive Systems, Inc. · Evanston, Illinois

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Chicago, Illinois

• Exercise and Protein Efficiency in T2DRecruiting

  N/A · University of Illinois at Urbana-Champaign · Urbana, Illinois

• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainRecruiting

  Phase 3 · Novo Nordisk A/S · Gurnee, Illinois

• Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaRecruiting

  Phase 3 · Immuneering Corporation · Arlington Heights, Illinois

• A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes MellitusRecruiting

  Phase 1 / Phase 2 · Otsuka Pharmaceutical Factory, Inc. · Chicago, Illinois

• Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN TrialsRecruiting

  N/A · Eastern Cooperative Oncology Group · Bristol, Tennessee

• Rare and Atypical Diabetes NetworkRecruiting

  N/A · University of South Florida · Chicago, Illinois

• Pancreatic Cancer Detection Consortium (PCDC) Prospective CohortsRecruiting

  N/A · Mayo Clinic · Peoria, Illinois

• A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerRecruiting

  Phase 2 · K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc · Mobile, Alabama

• Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesRecruiting

  Phase 4 · VA Office of Research and Development · Hines, Illinois

• Vitamin D for Prostate Endocrine TherapyRecruiting

  Phase 3 · University of Rochester · Danville, Illinois

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.